[144] Critical Metals Corp. SEC Filing

Rhea-AI Filing Summary

Critical Metals Corp. (CRML) filed a Form 144 reporting a proposed sale of 50,000 common shares through Oppenheimer & Co. Inc. on 10/10/2025 with an aggregate market value of $885,000. The shares were acquired from the issuer as compensation on 07/01/2025 and the filer reports no sales of the issuer's securities in the past three months. The filing includes the seller's representation that they know of no undisclosed material adverse information about the issuer.

Positive

• Disclosure provided of a planned sale of 50,000 shares valued at $885,000
• Securities were acquired as compensation on 07/01/2025, which is documented in the filing
• Broker and venue disclosed: Oppenheimer & Co. to execute on NASDAQ on 10/10/2025

Negative

• None.

Insights

Equity Capital Markets Analyst

TL;DR: An insider-sale notice for $885,000 in common stock scheduled for 10/10/2025.

The filing shows a planned brokered sale of 50,000 common shares via Oppenheimer & Co. The shares were granted as compensation on 07/01/2025, and no other sales by the filer were reported in the past three months.

Market impact is likely limited given the absolute size of the sale, but investors can watch trading around 10/10/2025 for short-term pressure on the stock's supply. Confirming whether this sale is part of a broader compensation program or an isolated disposition could add context to the issuer's share turnover over the coming quarter.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Oppenheimer & Co Inc 380 Knollwood Street Winston Salem NC 27103	50000	885000.00	104912853	10/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	07/01/2025	compensation	issuer			50000	07/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CRML Form 144 report?

The filing reports a proposed sale of 50,000 common shares valued at $885,000, to be sold through Oppenheimer & Co. on 10/10/2025.

When were the shares being sold by CRML acquired?

The shares were acquired from the issuer as compensation on 07/01/2025 and the filing records the acquisition amount as 50,000 shares.

Does the filer report other recent sales of CRML stock?

The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker will handle the CRML sale?

The sale is listed to be executed by Oppenheimer & Co. Inc, located at 380 Knollwood Street, Winston-Salem, NC.

What representation does the filer make about material information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.